[DOI] [PubMed] [Google Scholar] 89.Vanderheiden A., Harrison L.B., Warshauer J.T., Adams-Huet B., Li X., Yuan Q., Hulsey K., Dimitrov I., Yokoo T., Jaster A.W., et al
GlucoZencontains Cinnulin, which is made using a patented process that extracts the water-soluble components of cinnamon into a potent 20:1 extract (500 mg of Cinnulinis equivalent to approximately 10 g of whole cinnamon powder)
This is where the order actually becomes a physical product
Its orexigenic effect is an asset in this specific context
Compounding serves legitimate medical needs, particularly when: A patient needs a dose strength not commercially available A patient is allergic to an inactive ingredient in the commercial product A patient needs a different delivery method (e.g., liquid instead of pill) Commercial supply shortages create access issues Compounded drugs are not FDA-approved as finished products